Venous oxygen saturation is a clinical tool which integrates the whole body oxygen uptake-to-delivery (VO 2 -DO 2 ) relationship. In the clinical setting, in the absence of pulmonary artery catheter (PAC)-derived mixed venous oxygen saturation (SvO 2 ), the central venous oxygen saturation (ScvO 2 ) is increasingly being used as a reasonably accurate surrogate [1] . Central venous catheters (CVCs) are simpler to insert, and generally safer and cheaper than PACs. Th e CVC allows sampling of blood for measurement of ScvO 2 or even continuous monitoring if an oximetry catheter is being used. Th e normal range for SvO 2 is 68 to 77% and ScvO 2 is considered to be 5% above these values [2] .
Introduction
Venous oxygen saturation is a clinical tool which integrates the whole body oxygen uptake-to-delivery (VO 2 -DO 2 ) relationship. In the clinical setting, in the absence of pulmonary artery catheter (PAC)-derived mixed venous oxygen saturation (SvO 2 ), the central venous oxygen saturation (ScvO 2 ) is increasingly being used as a reasonably accurate surrogate [1] . Central venous catheters (CVCs) are simpler to insert, and generally safer and cheaper than PACs. Th e CVC allows sampling of blood for measurement of ScvO 2 or even continuous monitoring if an oximetry catheter is being used. Th e normal range for SvO 2 is 68 to 77% and ScvO 2 is considered to be 5% above these values [2] .
A decrease in hemoglobin (Hb, g/dl) is likely to be associated with a decrease in DO 2 when cardiac output (CO) remains unchanged, since DO 2 = CO x CaO 2 , where CaO 2 is arterial oxygen content and is ≈ Hb × SaO 2 x 1.34 (where SaO 2 is the arterial oxygen saturation in%; and 1.34 is the oxygen-carrying capacity of Hb in mlO 2 /g Hb), when one ignores the negligible oxygen not bound to Hb [1] . A decrease in Hb is one of the four determinants responsible for a decrease in SvO 2 (or ScvO 2 ), alone or in combination with hypoxemia (decrease in SaO 2 ), an increase in VO 2 without a concomitant increase in DO 2 , or a fall in cardiac output.
When DO 2 decreases, VO 2 is maintained (at least initially) by an increase in oxygen extraction (O 2 ER) since O 2 ER = VO 2 /DO 2 . As VO 2 ≈ (SaO 2 -SvO 2 ) × (Hb × 1.34 × CO) and DO 2 Because it integrates Hb, cardiac output, VO 2 and SaO 2 , the venous oxygen saturation therefore helps to assess the VO 2 -DO 2 relationship and tolerance to anemia during blood loss.
Venous oxygen saturation as a physiologic transfusion trigger
When DO 2 decreases beyond a certain threshold, it induces a decrease in VO 2 . Th is point is known as the critical DO 2 (DO 2 crit), below which there is a state of VO 2 -DO 2 dependency also called tissue dysoxia. In humans, dysoxia is usually present when SvO 2 falls below a critical 40-50% (SvO 2 crit); this may, however, also occur at higher levels of SvO 2 when O 2 ER is impaired. Usually eff orts in correcting cardiac output (by fl uids or inotropes), and/or Hb and/or SaO 2 and/or VO 2 must target a return of SvO 2 (ScvO 2 ) from 50 to 65-70% [4] . In sedated critically ill patients in whom life support was discontinued, the DO 2 crit was found to be approximately 3.8 to 4.5 mlO 2 /kg/min for a VO 2 of about 2.4 mlO 2 /g/ min; O 2 ER reached an O 2 ERcrit of 60% [5] with SvO 2 crit being ≈ 40%.
In a landmark study by Rivers et al. [6] , patients admitted to an emergency department with severe sepsis and septic shock were randomized to standard therapy (aiming for a central venous pressure [CVP] of 8-12 mmHg, mean arterial pressure (MAP) ≥ 65 mmHg, and urine output ≥ 0.5 ml/kg/h) or to early goal-directed therapy where, in addition to the previous parameters, an ScvO 2 of at least 70% was targeted by optimizing fl uid administration, keeping hematocrit ≥ 30%, and/or giving dobutamine to a maximum of 20 μg/kg/min. Th e initial ScvO 2 in both groups was low (49 ± 12%), suggesting a hypodynamic condition before resuscitation was started. From the 1 st to the 7 th hour, the amount of fl uid received was signifi cantly larger in the early goal-directed therapy patients (≈ 5,000 ml vs 3,500 ml, p < 0.001), fewer patients in the early goal-directed therapy group received vasopressors (27.4 vs 30.3%, p = NS), and signifi cantly more patients were treated with dobutamine (13.7 vs 0.8%, p < 0.001). It is noticeable that the number of patients receiving red blood cells (RBCs) was signifi cantly larger in the early goal-directed therapy group than in the control group (64.1 vs 18.5%) suggesting that the strategy of targeting a ScvO 2 of at least 70% was associated with more decisions to transfuse once fl uid, vasopressors, and dobutamine had been titrated to improve tissue oxygenation. In the follow-up period between the 7 th and the 72 nd hour, mean ScvO 2 was higher, mean arterial pH was higher, and plasma lactate levels and base excess were lower in patients who received early goal-directed therapy.
Organ failure score and mortality were signifi cantly diff erent in patients receiving standard therapy compared to early goal-directed therapy patients. Th is was the fi rst study to demonstrate that initiation of early goal-directed therapy to achieve an adequate level of tissue oxygenation by DO 2 (as judged by ScvO 2 monitoring) could significantly reduce mortality. In a prospective observational study [7] , we tested how well the ScvO 2 corresponded to the French recom mendations for blood transfusion and to the anesthesiologist's decision to transfuse. Th e French recommendations for blood transfusion were presented during a consensus conference organized in 2003 by the French Society of Intensive Care Medicine (Société de Réanimation de Langue Française, SRLF) [8] . Th ese recommendations are based on plasma Hb concentration and associated clinical state (Table 1) , and apart from in cardiac and septic patients, the threshold Hb value for blood transfusion is 7 g/dl. Sixty high risk surgical patients in whom the need for a blood transfusion was discussed postoperatively were included in the study [7] . Th ey were eligible for study inclusion if they were hemodynamically stable and equipped with a CVC. Th e decision to transfuse was taken by the anesthesiologist in charge of the patient. Th e anesthesiologist was aware of the SRLF recommendations; if requested, he/she was provided with the ScvO 2 value that was obtained at the same time as the blood was sampled for the Hb concentration. Th e following parameters were registered: Age, a history of cardiovascular disease, presence of sepsis, number of blood units transfused, agreement with the SRLF recommendations. A decision to transfuse was made in 53 of the 60 general and urologic surgical patients. ScvO 2 and Hb were measured before and after blood transfusion, together with hemodynamic parameters (heart rate, systolic arterial pressure). Patients were retrospectively divided into two groups according to the ScvO 2 before blood transfusion (< or ≥ 70%); each of these groups was further divided into two groups according to agreement or not with the SRLF recommendations for blood transfusion. Th e ScvO 2 threshold value of 69.5% (sensitivity 82%; specifi city 76%) was validated with a receiver operator characteristic (ROC) curve analysis ( Figure 1) .
Overall, demographic characteristics were similar (age, weight, number of blood units transfused) among the groups. Blood transfusion provided a signifi cant and approxi mately similar increase in hemoglobin concentration for all patients in the four groups but the ScvO 2 value increased signifi cantly only in patients with ScvO 2 < 70% before blood transfusion ( Figure 2 and Table 2 ). . ROC curve analysis illustrating the usefulness of ScvO 2 measurement before blood transfusion in order to predict a minimal 5% increase in ScvO 2 after BT. The threshold value for ScvO 2 with the best sensitivity and best specifi city was 69.5% (*sensitivity: 82%, specifi city: 76%; area under the curve: 0.831 + 0.059). Adapted from [7] with permission. Th e heart rate and systolic arterial pressure did not help in the decision to transfuse. Th e conclusions of this observational study were as follows: 1) Twenty of the 53 patients (37.7%) received a blood transfusion against SRLF recommendations; 2) thirteen of these 20 patients (65%) had an ScvO 2 < 70% and nevertheless seemed to benefi t from the blood transfusion (according to the VO 2 /DO 2 relationship), and one may speculate that the fact that they did not comply with the SRLF recommendations for blood transfusion could have contributed to a "lack of blood transfusion" in these patients; indeed, according to the ScvO 2 (which [6] and our own observations [7] we can conclude that ScvO 2 appears to be an interesting parameter to help with transfusion decisions in hemodynamically unstable patients with severe sepsis or in stable high-risk surgical patients equipped with a CVC. ScvO 2 can be proposed as a simple and universal physiologic transfusion trigger. Th is suggestion merits a controlled randomized study in which patients would be separated into two treatment groups: 1) A control group in which the decision to transfuse would be made according to Hb threshold values (similar to those presented by the SRLF); 2) an ScvO 2 goaldirected group in which the decision to transfuse would be made according to an ScvO 2 value < 70% as soon as the Hb value was less than 10 g/dl (hematocrit < 30%) providing that the CVP was 8 to 12 mmHg.
The concept of physiologic transfusion trigger
In an 84-year-old male Jehovah's Witness undergoing profound hemodilution, the DO 2 crit was 4.9 mlO 2 /kg/ min for a VO 2 of about 2.4 mlO 2 /kg/min; the Hb value at the DO 2 crit was 3.9 g/dl [9] . Th is Hb value can be defi ned as the critical Hb value. Consistent with these results, in young, healthy, and conscious (which means higher VO 2 ) volunteers undergoing acute hemodilution with 5% albumin and autologous plasma, DO 2 crit was found to be less than 7.3 mlO 2 /kg/min for a VO 2 of 3.4 mlO 2 /kg/min [10] and an Hb value of 4.8 g/dl. Th e same investigators studied healthy resting humans to test whether acute isovolemic reduction of blood hemoglobin concentration to 5 g/dl would produce an imbalance in myocardial oxygen supply and demand, resulting in myocardial ischemia [11] . Heart rate increased from 63 ± 11 (baseline measured before hemodilution began) to 94 ± 14 beats/ min (a mean increase of 51 ± 27%; p < 0.0001), whereas MAP decreased from 87 ± 10 to 76 ± 11 mmHg (a mean decrease of 12 ± 13%; p < 0.0001), mean diastolic blood pressure decreased from 67 ± 10 to 56 ± 10 mmHg (a mean decrease of 15 ± 16%; p < 0.0001), and mean systolic blood pressure decreased from 131 ± 15 to 121 ± 16 mmHg (a mean decrease of 7 ± 11%; p = 0.0001). Electrocardiographic (EKG) changes were monitored continuously using a Holter EKG recorder for detection of myocardial ischemia. During hemodilution, transient, reversible ST-segment depression developed in three asymptomatic subjects at hemoglobin concentrations of 5 g/dl. Th e subjects who had EKG ST-segment changes had signifi cantly higher maximum heart rates (110 to 140 beats/min) than those without EKG changes, despite having similar baseline values. Th e higher heart rates that developed during hemodilution may have contributed to the development of an imbalance between myocardial oxygen supply and demand resulting in EKG evidence of myocardial ischemia. An approach to the myocardial oxygen balance is off ered by the product systolic arterial pressure × heart rate which should remain below 12,000. For heart rate = 110 beats/min, if systolic arterial pressure is 120 mmHg, systolic arterial pressure × heart rate = 13,200 and may be considered too high for the myocardial VO 2 .
In 20 patients older than 65 years and free from known cardiovascular disease, Hb was decreased from 11.6 ± 0.4 to 8.8 ± 0.3 g/dl [12] . With stable fi lling pressures, cardiac output increased from 2.02 ± 0.11 to 2.19 ± 0.10 l/min/m 2 (p < 0.05) while systemic vascular resistance (SVR) decreased from 1796 ± 136 to 1568 ± 126 dynes/s/cm 5 (p < 0.05) and O 2 ER increased from 28.0 ± 0.9 to 33.0 ± 0.8% (p < 0.05) resulting in stable VO 2 during hemodilution. While no alterations in ST segments were observed in lead II, ST segment deviation became slightly less negative in lead V 5 during hemodilution, from -0.03 ± 0.01 to -0.02 ± 0.01mV (p < 0.05). Th e authors concluded that isovolemic hemodilution to a hemoglobin value of about 8.8 g/dl was the limit that could be tolerated in these patients [12] .
In 60 patients with coronary artery disease receiving chronic beta-adrenergic blocker treatment and scheduled for coronary artery bypass graft (CABG) surgery, Hb was decreased from 12.6 ± 0.2 to 9.9 ± 0.2 g/dl (p < 0.05) [13] . With stable fi lling pressures, cardiac output increased from 2.05 ± 0.05 to 2.27 ± 0.05 l/min/m 2 (p < 0.05) and O 2 ER from 27.4 ± 0.6 to 31.2 ± 0.7% (p < 0.05), resulting in stable VO 2 . No alterations in ST segments were observed in leads II and V 5 during hemodilution. Individual increases in cardiac index and O 2 ER were not linearly related to age or left ventricular ejection fraction [13] .
Healthy young volunteers were also tested with verbal memory and standard computerized neuropsychologic tests before and twice after acute isovolemic reduction of their Hb concentration to 5.7 ± 0.3 g/dl [14] . Heart rate, MAP, and self-assessed sense of energy were recorded at the time of each test. Reaction time for Digit-Symbol Substitution Test (DSST) increased, delayed memory was degraded, MAP and energy level decreased, and heart rate increased (all p < 0.05). Increasing PaO 2 to 406 ± 47 mmHg reversed the DSST result and the delayed memory changes to values not diff erent from those at the baseline Hb concentration of 12.7 ± 1.0 g/dl, and decreased heart rate (p < 0.05) although MAP and energy level changes were not altered with increased PaO 2 during acute anemia. In that study, the authors confi rmed that acute isovolemic anemia subtly slows human reaction time, degrades memory, increases heart rate, and decreases energy levels [14] .
Subsequent studies identifi ed the cause of the observed cognitive function defi cits in impaired central processing as quantifi ed by measurement of the P300 latency. Th e P300 response was signifi cantly prolonged when unmedi cated healthy volunteers were hemodiluted from hemo globin concentrations of 12.4 ± 1.3 to 5.1 ± 0.2 g/dl [15] . Th e increased P300 latencies could be reversed to values not signifi cantly diff erent from baseline when inspired oxygen concentration was increased from 21 (room air) to 100%. Th ese results suggest that P300 latency is a variable that is sensitive enough to predict subtle changes in cognitive function. Accordingly, increase in the P300 latency above a certain threshold may serve as a monitor of inadequate cerebral oxygenation and as an organ-specifi c transfusion trigger in the future. Spahn and Madjdpour recently commented [16] that Weiskopf et al. [15, 17] have opened a "window to the brain" with respect to monitoring the adequacy of cerebral oxygenation during acute anemia.
Th ese observations and results clearly indicate that there is no 'universal' Hb threshold that could serve as a reliable transfusion trigger and that transfusion guide lines should take into account the patient's individual ability to tolerate and to compensate for the acute decrease in Hb concentration. Useful transfusion triggers should rather consider signs of inadequate tissue oxygenation that may occur at various hemoglobin concentrations depending on the patient's underlying disease(s) [18] .
Conclusion
Physiologic transfusion triggers should progressively replace arbitrary Hb-based transfusion triggers [19] . Th e same conclusions were drawn by Orlov et al. in a recent trial using a global oxygenation parameter for guiding RBC transfusion in cardiac surgery [20] . Th e use of goaldirected erythrocyte transfusions should render the manage ment of allogeneic red cell use more effi cient and should help: 1) in saving blood and avoiding unwanted adverse eff ects; and 2) in promoting and optimizing the adequacy of this life-saving treatment [16] . Th ese 'physiologic' transfusion triggers can be based on signs and symptoms of impaired global (lactate, SvO 2 or ScvO 2 ) or, even better, regional tissue (EKG ST-segment, DSST or P300 latency) oxygenation; they do, however, have to include two important simple hemodynamic targets: heart rate and MAP or systolic arterial pressure.
